These findings suggest that Metformin mitigates kidney injury and improves renal pathology, which is associated with decreased OGT, increased OGA expression, and overall decreased O-GlcNAc modification levels in patients with early or moderate DN. Here, OGA is linked to liver dysplastic nodule.